Medical News

RSS

PhRMA: 460 medicines in development for rare diseases

America's biopharmaceutical research companies are intensifying research into rare diseases, which often are among the most devastating to patients and complex for researchers. A record 460 medicines for rare diseases are in late stages of the pipeline, either in clinical trials or awaiting Food and Drug Administration (FDA) review, according to a report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).

24 Feb 2011

Foreign-born scientists and artists receive sixth annual Vilcek Prize for Biomedical Science

The Vilcek Foundation is pleased to announce the 2011 winners of its annual prizes honoring the contributions of foreign-born scientists and artists.

24 Feb 2011

Isis Pharma announces ISIS-CRPRx Phase 1 trial results in diseases with elevated CRP

Isis Pharmaceuticals, Inc. announced today the results from a Phase 1 clinical trial in which ISIS-CRPRx produced statistically significant reductions in C-reactive protein in the cohort of subjects in the study with elevated CRP.

24 Feb 2011

New guidelines recommend routine use of allergy tests to improve quality of care in children

The first guidelines for food allergy in children and young people issued by NICE, National Institute for health and Clinical Excellence, recommend routine use of allergy tests in NHS primary care and community settings to confirm suspected food allergy.

24 Feb 2011

Wisconsin's benefit backlash spreads to other states

The public employee reaction is occurring in other states, too, as newly elected conservative governors attempt to roll-back health and pension benefits.

24 Feb 2011

Study finds link between fasting serum glucose levels and in-hospital mortality in elderly non-diabetic patients

A two-country hospital study of 808 elderly patients found a strong association between high, undiagnosed blood glucose in non-diabetic patients and increased hospital death rates, according to the March issue of IJCP, the International Journal of Clinical Practice.

24 Feb 2011

Supreme Court raises the bar for suits against vaccine producers

The decision, announced Tuesday, will make it harder for parents who maintain that their children were injured by vaccines to file lawsuits against drug makers. Public health advocates say the ruling will help maintain the nation's vaccine supply levels.

24 Feb 2011

Shock Doctor signs three-year endorsement contract with NFL

Minneapolis-based Shock Doctor – the authentic market leader and creators of innovative, unique performance-driven sports protection and the undisputed leader in mouthguard technology – announced today it has signed a three-year endorsement contract with NFL San Diego Chargers running back Ryan Mathews.

24 Feb 2011

Onyx, Bayer initiate patient enrollment in Nexavar Phase 3 trial for breast cancer treatment

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced the companies have begun enrolling patients in a Phase 3 randomized, double-blind, placebo-controlled trial evaluating Nexavar tablets in combination with the oral chemotherapeutic agent, capecitabine, versus placebo plus capecitabine for the treatment of patients with advanced breast cancer.

24 Feb 2011

Integra LifeSciences fourth quarter revenues increase 6% to $10.6 million

Integra LifeSciences Holdings Corporation today reported its financial results for the fourth quarter and full year ending December 31, 2010. Total revenues for the fourth quarter were $194.1 million, reflecting an increase of $10.6 million, or 6%, over the fourth quarter of 2009.

24 Feb 2011

FDA's tobacco advisory committee continues to ignore CRE statements

FDA's tobacco advisory committee continues to ignore statements by the Center for Regulatory Effectiveness that its organic statute requires it to address the negative health impacts of contraband cigarettes.

24 Feb 2011

MRG projects growth standouts in European surgical procedures for next five years

According to Millennium Research Group, the global authority on medical technology market intelligence, growth standouts in European surgical procedures over the next five years will be in percutaneous heart valve procedures, arthroscopy and single-port laparoscopy.

24 Feb 2011

State roundup: Budget cuts to affect health care for state workers, disabled, elderly

A year after making a name for himself by slashing spending, New Jersey Gov. Chris Christie presented a $29.4 billion budget on Tuesday that makes nips and tucks to programs—notably Medicaid—but puts much of the state in a holding pattern.

24 Feb 2011

Scientists confirm presence of infectious life forms in waste, drinking water treatment plants

"The presence of two resistent forms of protozoons, the oocysts from the Cryptosporidium genus and cysts of the Giardia genus, is one of the greatest public health problems in water supply, because these parasites can easily survive our water treatment systems", Jos- Antonio Castro Hermida, a scientist at the Galician Institute for Food Quality in the Xunta de Galicia, tells SINC.

24 Feb 2011

Steroid administration may impact immune system in children with asthma

Children experiencing an asthma attack who are treated with a short burst of oral steroids may have a transient depression of immune response according to a new study led by Universit- de Montr-al.

24 Feb 2011

The GOP strategy to defund the health law

With a shutdown looming, the cuts included in the continuing resolution that would fund the federal government for the current fiscal year offer insights into what Republicans view as the measure's soft spots. Still, Dems are holding the line.

24 Feb 2011

Roche receives DOD approval to provide remote service and support for its lab analyzers

Roche announced today that it has received approval from the U.S. Department of Defense to provide remote service and support for its lab analyzers at Womack Army Medical Center through the DOD's secure B2B gateway. Roche is the first in-vitro diagnostics manufacturer to be approved by the DOD for this remote access.

From Roche Sequencing and Life Science 24 Feb 2011

Medical News

PhRMA: 460 medicines in development for rare diseases

Foreign-born scientists and artists receive sixth annual Vilcek Prize for Biomedical Science

Isis Pharma announces ISIS-CRPRx Phase 1 trial results in diseases with elevated CRP

New guidelines recommend routine use of allergy tests to improve quality of care in children

Wisconsin's benefit backlash spreads to other states

Study finds link between fasting serum glucose levels and in-hospital mortality in elderly non-diabetic patients

Supreme Court raises the bar for suits against vaccine producers

Shock Doctor signs three-year endorsement contract with NFL

Onyx, Bayer initiate patient enrollment in Nexavar Phase 3 trial for breast cancer treatment

Integra LifeSciences fourth quarter revenues increase 6% to $10.6 million

FDA's tobacco advisory committee continues to ignore CRE statements

MRG projects growth standouts in European surgical procedures for next five years

State roundup: Budget cuts to affect health care for state workers, disabled, elderly

Scientists confirm presence of infectious life forms in waste, drinking water treatment plants

Steroid administration may impact immune system in children with asthma

The GOP strategy to defund the health law

Roche receives DOD approval to provide remote service and support for its lab analyzers

Positive results from Vertex VX-770 Phase 3 STRIVE study in patients with CF

Scientists suggest that lateral habenula can be a prime locus of human depression

HHS issues home health grants to states

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Latest News